A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The Food and Drug Administration is implementing more rigorous standards for administering the COVID-19 vaccine and experts ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

“The 2024–2025 COVID vaccine, which was released last fall, is still recommended for everyone aged six months or over,” the ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...